Committee for proprietary medicinal products (CPMP) points to consider on adjustment for baseline covariates
Points to consider on efficacy evaluation of hemoglobin‐ and perfluorocarbon‐based oxygen carriers. Center for Biologics Evaluatio...
Developing core outcome sets for clinical trials: issues to consider
Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effe...
The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990
Looking back to see forward in services marketing: some ideas to consider
Alcohol and cardiovascular disease--more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking a...
RETURNING GENETIC RESEARCH RESULTS TO INDIVIDUALS: POINTS‐TO‐CONSIDER
Aspects to consider when detecting and measuring lipid peroxidation
Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introdu...
